News
Is Mission Produce Ready to Deliver on Global Sourcing Hopes?
Mission Produce, Inc. AVO is positioning itself as more than just an avocado giant. With record second-quarter fiscal 2025 revenues of $380.3 million, up 28% year over year, the company has
Salesforce Q2 Earnings Surpass Estimates, Revenues Rise Y/Y
Salesforce CRM reported second-quarter fiscal 2026 non-GAAP earnings of $2.91 per share, which beat the Zacks Consensus Estimate by 5.1%. The bottom line improved 13.7% year over year.
Salesforce’s
Can McDonald's Tech Platform Unlock a New Wave of Margin Expansion?
McDonald’s Corporation MCD is leaning into a multi-year, technology-led transformation that could reshape its cost structure and improve customer engagement. The company’s “Accelerating the Arches”
Celsius Adjusted EBITDA Doubles in Q2: How Durable Are Cost Synergies?
Celsius Holdings, Inc. (CELH) reported a staggering 109% increase in adjusted EBITDA in the second quarter of 2025, reaching $210.3 million compared with $100.4 million in the same period a year
IMVT Stock Up 11% on Upbeat Batoclimab Hyperthyroidism Study Results
Immunovant, Inc. IMVT shares gained 10.8% on Wednesday after the company announced new six-month off-treatment results from a proof-of-concept study evaluating its investigational candidate
Is Primoris Services Stock Worth Buying at a Premium P/E Valuation?
Primoris Services Corporation PRIM shares are trading at a premium compared with the Zacks Building Products – Heavy Construction industry. The company’s forward 12-month price-to-earnings (P/E)
Shell Shelves Rotterdam Biofuels Plant, Prioritizes Competitive Edge
Shell plc’s SHEL subsidiary, Shell Nederland Raffinaderij B.V., has scrapped its plan to restart construction of a biofuels facility at the Shell Energy and Chemicals Park in Rotterdam.
Balancing
Here's What Key Metrics Tell Us About Gitlab (GTLB) Q2 Earnings
For the quarter ended July 2025, GitLab Inc. (GTLB) reported revenue of $235.96 million, up 29.2% over the same period last year. EPS came in at $0.24, compared to $0.15 in the year-ago quarter.
The
Weak Private Payrolls Data for August
We have lots of economic data out prior to today’s opening bell. Chief among them is the latest “Jobs Week” report, private-sector payrolls from Automatic Data Processing ADP. A headline of +54K new
4 PEG-Rated GARP Stocks That Offer Both Value and Growth
In the equity market, investments need to be prudently hedged to overcome uncertainties and limit losses related to external shocks. A question that often arises is whether one should resort to a
SNY Down Despite Eczema Candidate Meeting Goal in Phase III Study
Sanofi SNY announced positive data from the phase III COAST 1 study, which evaluated the safety and efficacy of its anti-OX40L mAb, amlitelimab, for treating moderate-to-severe atopic dermatitis
Is the Recent Pipeline Progress on its NSCLC Drug Enough for BDTX?
Black Diamond Therapeutics, Inc.’s BDTX lead pipeline candidate, silevertinib, is a brain penetrant, fourth-generation epidermal growth factor receptor (“EGFR”) MasterKey inhibitor targeting
Here's Why Investors Should Bet on FedEx Stock Right Now
FedEx Corporation’s FDX top line is bolstered by its robust segmental performance and solid operational efficiency, boosting the company’s prospects. Fleet modernization initiatives are also
AES Advances on Strong Renewable Energy Buildout and LNG Expansion
The AES Corporation AES is advancing its renewable energy generation by expanding solar, wind and battery storage capacity to achieve its long-term clean energy targets. It has also been boosting
Implied Volatility Surging for American Coastal Insurance Stock Options
Investors in American Coastal Insurance Corporation ACIC need to pay close attention to the stock based on moves in the options market lately. That is because the Nov. 21, 2025 $6.00 Put had some of
August ADP Weaker at +54K, & More
Thursday, September 4, 2025We have lots of economic data out prior to today’s opening bell. Chief among them is the latest “Jobs Week” report, private-sector payrolls from Automatic Data Processing
TEVA Stock Up More Than 19% in a Month: Buy, Sell or Hold the Stock?
Teva Pharmaceutical Industries Limited’s TEVA shares have risen 19.4% in the past month. A key driver of the stock price increase was its mixed second-quarter results announced on July 30. Teva’s
Huntington Ingalls Secures Contract to Support Aircraft Carrier
Huntington Ingalls Industries Inc.’s HII subsidiary, HII Fleet Support Group LLC, recently won a contract to support the refueling and complex overhaul, as well as the engineering maintenance assist
GIII's Q2 Earnings Beat, FY26 Sales View Trimmed Amid Tariff Headwinds
G-III Apparel Group, Ltd. GIII has reported second-quarter fiscal 2026 results, wherein both top and bottom lines beat the Zacks Consensus Estimate. However, the company’s net sales and earnings
USB Resumes Institutional Bitcoin Custody Service Amid Deregulations
U.S. Bancorp USB has restarted its bitcoin custody service following a three-year pause with the easing of the regulatory environment, given the Trump administration’s favorable stance toward
Do Options Traders Know Something About ACI Worldwide Stock We Don't?
Investors in ACI Worldwide, Inc. ACIW need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 19, 2025 $35.00 Put had some of the highest
Bet on These 5 Low-Leverage Stocks Amid Higher Treasury Yields
All three major U.S. stock indices slipped on Sept. 3, 2025, owing to multiple factors, including rising tariff concerns, higher long-term Treasury yields and inflation fears, that might have caused
HPE Q3 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Up 2%
Hewlett Packard Enterprise’s HPE shares rose 2% during yesterday’s extended trading session after it reported better-than-expected results for third-quarter fiscal 2025. The company’s non-GAAP
Descartes Q2 Earnings Lag, Top Line Up Y/Y Despite Global Trade Woes
Descartes Systems (DSGX) reported second-quarter fiscal 2026 non-GAAP earnings per share (EPS) of 43 cents, which lagged the Zacks Consensus Estimate by 12.2%. The bottom line, however, grew 7.5%


